← Back to All Filings

JNJ Exec Sells $4.2M in Stock Following Option Exercise

Low SignificanceOctober 20, 2025 at 7:31:50 PM EDT

JOHNSON & JOHNSON

$JNJ4CIK: 0000200406

Subscribe to track JNJ

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

JNJ Exec Sells $4.2M in Stock Following Option Exercise

Company: JOHNSON & JOHNSON (JNJ) Form: 4 | Filed: 2025-10-20 Significance: Low

Insider: REED JOHN C Title: EVP, Innovative Medicine, R&D | Relationship: Officer

Transaction: • Type: Sell (following option exercise) • Shares: 21,721 • Price: $192.71 • Value: $4,186,162 • Owned After: 10,658

Key Insight: An executive exercised stock options and immediately sold the shares, a common practice for compensation and tax purposes. The transaction value is negligible compared to JNJ's market cap.

Market Context: This is a routine executive compensation event for a mega-cap company and is not considered a bearish signal on its own.

Comprehensive Analysis

SEC Filing Analysis: JOHNSON & JOHNSON (JNJ)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An executive at Johnson & Johnson conducted a common 'cashless exercise' of stock options, acquiring 21,721 shares at $157.92 and immediately selling them for a total of $4.2 million at an average price of $192.71.
  • Market Impact: The transaction is immaterial relative to Johnson & Johnson's $465 billion market capitalization and is unlikely to have any impact on the stock price.

Company Information

FieldValue
CompanyJOHNSON & JOHNSON
Ticker SymbolJNJ
CIK0000200406
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameREED JOHN C
CIK0001181561
Title/PositionEVP, Innovative Medicine, R&D
RelationshipOfficer

Transaction Details

This filing reports two related non-derivative transactions: an option exercise and a subsequent sale.

FieldValue (Sale Transaction)
Form Type4
Transaction Date2025-10-17
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved21,721
Price Per Share$192.71
Total Value$4,186,161.85
Shares Owned After10,658
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,186,161.85
% of Market Cap0.0009%
Shares Transacted21,721
% of Shares Outstanding0.0009%
Post-Transaction Ownership10,658 shares (0.00044% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company like Johnson & Johnson with a market capitalization of $465.34 billion, a $4.2 million transaction is financially insignificant and represents a tiny fraction of daily trading volume.
  • Ownership Concentration: The insider's final holding of 10,658 shares is a negligible percentage of the total shares outstanding, indicating very low ownership concentration from this individual.
  • Dilution Impact: The transaction originated from an option exercise, which introduces 21,721 new shares. This represents a 0.0009% increase in shares outstanding, which is a completely immaterial dilution event for existing shareholders.
  • Transaction Significance: The sale liquidated approximately 67% of the shares the insider held after the option exercise (21,721 sold out of 32,379). While a large percentage of the insider's personal holdings, the overall size is too small relative to the company's scale to be considered significant. This is a typical strategy to cover the option exercise cost, pay taxes, and realize a profit.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a routine executive compensation event. The market understands that 'exercise-and-sell' transactions are often pre-planned and not indicative of an insider's negative outlook on the company's future.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction size is too small to affect JNJ's typical trading volume.
  • Sentiment Indicator: Neutral. This type of filing is common and does not typically influence market sentiment for a company of this size.

Investment Insights

Positive Market Indicators

  • The exercise of options indicates the stock price is well above the strike price, reflecting past stock performance.

Risk Factors

  • No new risk factors are indicated by this filing. The sale is not large enough to be considered a signal of concern.

Key Takeaways

  1. Routine Compensation: This is a standard executive compensation event, not a strategic investment decision.
  2. Immaterial Size: The transaction's value and share count are negligible compared to Johnson & Johnson's total market cap and shares outstanding.
  3. No Bearish Signal: The sale was directly tied to an option exercise and should not be interpreted as the insider losing faith in the company.

Additional Context

Transaction Notes

  • Special Circumstances: The filing details a two-step process: exercising employee stock options to acquire shares (Code 'M') and then immediately selling those shares on the open market (Code 'S'). The sale price of $192.71 is a weighted average, as noted in the filing's footnotes.
  • Market Environment: This transaction is a function of the executive's compensation plan and vesting schedule, rather than a reaction to current market conditions.
Topics:#SECFiling#InsiderTrading#JNJ#JohnsonAndJohnson#Form4#InsiderSell#StockMarket#Investing#ExecutiveComp

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.